Heath related quality of life (HRQOL) assessment for patients with advanced renal cell carcinoma (mRCC) treated with tyrosine kinase inhibitor (TKI) using electronic patient reported outcome (PRO) in daily clinical practice
2017 ◽
Vol 25
(12)
◽
pp. 3775-3783
◽
Keyword(s):
2006 ◽
Vol 132
(8)
◽
pp. 908
2010 ◽
Vol 106
(11)
◽
pp. 1643-1647
◽
2012 ◽
Vol 48
(3)
◽
pp. 311-323
◽
Keyword(s):